Related Experiment Video
Updated: Sep 9, 2025
Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
miR-155 aggravates inflammation in MRSA pneumonia by modulating macrophage polarization
Yunfeng Shi1,2, Xiaohan Shi3, Yang Yang1
1Department of Medical Intensive Care Unit, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Background:
Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is a severe infection with high mortality, where alveolar macrophages (AMs) play a critical role in host defense through M1 polarization. MicroRNA-155 (miR-155) is known to modulate immune responses, but its specific role in AM polarization during MRSA pneumonia remains unclear. This study investigates how miR-155 regulates M1 macrophage polarization and MRSA pneumonia.
Methods:
The experiments were performed in both vitro and in miR-155 knockout mice. The activity of miR-155 and polarization of AMs were evaluated using scanning electron microscopy, immunofluorescence, enzyme-linked immunosorbent assay (ELISA), and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Lung pathology, inflammatory markers, and potential signaling pathways (particularly AKT/mTOR) were analyzed.
Results:
miR-155 expression was significantly upregualted in MRSA infection, while miR-155 promoted M1 macrophage polarization as demonstrated by distinct morphological changes, elevated CD86 levels, and increased IL-6 production. miR-155 deficiency attenuated this response, reducing inflammatory cytokine release and lung pathology while impairing AKT/mTOR pathway activation, indicating that miR-155 exacerbates MRSA-induced pneumonia by driving M1 polarization through AKT/mTOR signaling.
Conclusions:
Our findings reveal that miR-155 modulates M1 macrophage polarization and aggrevates MRSA-induced pneumonia by activating the AKT/mTOR pathway. This study provides new insights into host-pathogen interactions in MRSA infection, suggesting miR-155 as a potential therapeutic target.
Insights
MicroRNA-155 (miR-155) exacerbates Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia by promoting M1 macrophage polarization via the AKT/mTOR pathway. Inhibiting miR-155 may offer a therapeutic strategy for MRSA infections.
Area of Science:
- Immunology
- Microbiology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is a severe infection with high mortality.
- Alveolar macrophages (AMs) are key in host defense via M1 polarization.
- The role of microRNA-155 (miR-155) in AM polarization during MRSA pneumonia is unclear.
Purpose of the Study:
- To investigate the role of miR-155 in regulating M1 macrophage polarization.
- To elucidate the mechanism by which miR-155 influences MRSA pneumonia.
Main Methods:
- Experiments conducted in vitro and in miR-155 knockout mice.
- Assessed miR-155 activity and AM polarization using SEM, immunofluorescence, ELISA, and RT-qPCR.
- Analyzed lung pathology, inflammatory markers, and AKT/mTOR signaling.
Main Results:
- miR-155 expression was significantly upregulated during MRSA infection.
- miR-155 promoted M1 polarization, evidenced by morphological changes, increased CD86, and IL-6 production.
- miR-155 deficiency reduced inflammation and lung pathology, impairing AKT/mTOR activation.
Conclusions:
- miR-155 exacerbates MRSA pneumonia by driving M1 polarization through AKT/mTOR activation.
- Findings suggest miR-155 as a potential therapeutic target for MRSA infections.
